サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1625477

白金制剤がん治療薬市場、規模、シェア、動向、産業分析レポート：タイプ別、用途別、流通チャネル別、地域別 - 市場予測、2025年～2034年

Platinum-Based Cancer Drugs Market Size, Share, Trends, Industry Analysis Report: By Type, Application, Distribution Channel, and Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 118 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
白金制剤がん治療薬市場、規模、シェア、動向、産業分析レポート：タイプ別、用途別、流通チャネル別、地域別 - 市場予測、2025年～2034年
出版日: 2024年12月01日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の白金制剤がん治療薬市場規模は2034年までに27億3,324万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

卵巣がん、肺がん、大腸がんなど、効果的な化学療法を必要とするさまざまながんの有病率の増加が、白金制剤がん治療薬市場の成長を牽引しています。主な市場促進要因としては、固形がん治療におけるシスプラチン、カルボプラチン、オキサリプラチンなどの白金制薬剤の継続的な有効性、治療成績を高める併用療法や個別化医療の進歩などが挙げられます。がん治療へのアクセスが拡大している新興国市場や、副作用の軽減やドラッグデリバリーの改善を目指した新薬製剤の開発にもビジネスチャンスが存在します。

併用療法の台頭、毒性軽減への注力、白金制剤のジェネリック医薬品の増加など、白金制剤をベースとするがん治療薬の市場動向は、予測期間中の市場全体の拡大に寄与すると思われます。研究が進み、白金制剤の新たな用途が模索されるにつれて、市場は継続的な成長を遂げ、より優れたがん治療に対する需要と安価な治療に対する世界のニーズの両方に対応していくものと思われます。

白金制剤がん治療薬市場レポートハイライト

タイプ別では、シスプラチンが卵巣がんや精巣がんなどさまざまながんの治療に長年使用され、有効であることから、白金制剤がん治療薬市場シェアを独占しています。しかし、大腸がん治療や併用療法への応用が進んでいるオキサリプラチン部門が最も急成長しています。

卵巣がんは、シスプラチンやカルボプラチンのような白金制剤の高い治療効果により、用途別では最大の市場シェアを占めています。肺がんは、主に非小細胞肺がんの罹患率の上昇と白金制剤と他の薬剤の併用により、最も急速に成長している分野です。

流通チャネル別では、入院治療やがん治療において白金制剤を含む化学療法薬の主要な供給元である病院内薬局が市場を独占しています。オンライン薬局は、遠隔地でのヘルスケアや処方箋の補充や外来治療における患者の利便性向上の動向により、最も高い成長を遂げています。

北米が世界市場で最大のシェアを占めているが、これは主に同地域の先進ヘルスケアインフラと高いがん罹患率によるものです。アジア太平洋地域は最も成長率の高い地域であり、がん罹患率の増加、医療アクセスの改善、中国やインドなどにおける白金制剤の採用増加などがその要因です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 白金制剤がん治療薬の世界市場の洞察

  • 市場スナップショット
  • 白金制剤がん治療薬市場力学
    • 促進要因と機会
      • 白金制剤がん治療薬の化学療法の採用増加
      • 併用療法に関する進行中の調査
    • 抑制要因と課題
      • 高コスト
  • PESTEL分析
  • 白金制剤がん治療薬市場の流通チャネル動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界の白金制剤がん治療薬市場：タイプ別

  • 主な調査結果
  • イントロダクション
  • シスプラチン
  • オキサリプラチン
  • カルボプラチン
  • その他

第6章 世界の白金制剤がん治療薬市場：用途別

  • 主な調査結果
  • イントロダクション
  • 大腸がん
  • 卵巣がん
  • 肺がん
  • その他

第7章 世界の白金制剤がん治療薬市場：流通チャネル別

  • 主な調査結果
  • イントロダクション
  • 病院併設薬局
  • 小売薬局
  • オンライン薬局

第8章 世界の白金制剤がん治療薬市場：地域別

  • 主な調査結果
  • イントロダクション
    • 白金制剤がん治療薬市場評価：地域、2020-2034年
  • 北米
    • 北米：タイプ別、2020-2034年
    • 北米：用途別、2020-2034年
    • 北米：流通チャネル別、2020-2034年
    • 米国
    • カナダ
  • 欧州
    • 欧州：タイプ別、2020-2034
    • 欧州：用途別、2020-2034年
    • 欧州：流通チャネル別、2020-2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋：タイプ別、2020-2034年
    • アジア太平洋：用途別、2020-2034年
    • アジア太平洋：流通チャネル別、2020-2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ
    • 中東・アフリカ：タイプ別、2020-2034年
    • 中東・アフリカ：用途別、2020-2034年
    • 中東・アフリカ：流通チャネル別、2020-2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ
  • ラテンアメリカ
    • ラテンアメリカ：タイプ別、2020-2034年
    • ラテンアメリカ：用途別、2020-2034年
    • ラテンアメリカ：流通チャネル別、2020-2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Sanofi
  • Pfizer
  • Novartis
  • Johnson & Johnson
  • Teva Pharmaceutical Industries
  • Hikma Pharmaceuticals
  • Mylan
  • AstraZeneca
  • GlaxoSmithKline
  • Bayer
  • Merck & Co.
  • Amgen
  • Sun Pharmaceutical Industries
図表

List of Tables:

  • Table 1 Global Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 2 Global Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 3 Global Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 4 North America: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 5 North America: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 6 North America: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 7 U.S.: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 8 U.S.: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 9 U.S.: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 10 Canada: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 11 Canada: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 12 Canada: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 13 Europe: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 14 Europe: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 15 Europe: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 16 UK: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 17 UK: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 18 UK: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 19 France: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 20 France: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 21 France: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 22 Germany: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 23 Germany: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 24 Germany: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 25 Italy: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 26 Italy: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 27 Italy: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 28 Spain: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 29 Spain: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 30 Spain: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 31 Netherlands: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 32 Netherlands: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 33 Netherlands: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 34 Russia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 35 Russia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 36 Russia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 37 Rest of Europe: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 38 Rest of Europe: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 39 Rest of Europe: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 40 Asia Pacific: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 41 Asia Pacific: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 42 Asia Pacific: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 43 China: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 44 China: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 45 China: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 46 India: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 47 India: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 48 India: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 49 Malaysia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 50 Malaysia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 51 Malaysia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 52 Japan: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 53 Japan: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 54 Japan: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 55 Indonesia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 56 Indonesia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 57 Indonesia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 58 South Korea: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 59 South Korea: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 60 South Korea: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 61 Australia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 62 Australia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 63 Australia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 64 Rest of Asia Pacific: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 65 Rest of Asia Pacific: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 66 Rest of Asia Pacific: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 67 Middle East & Africa: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 68 Middle East & Africa: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 69 Middle East & Africa: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 70 Saudi Arabia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 71 Saudi Arabia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 72 Saudi Arabia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 73 UAE: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 74 UAE: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 75 UAE: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 76 Israel: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 77 Israel: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 78 Israel: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 79 South Africa: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 80 South Africa: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 81 South Africa: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 82 Rest of Middle East & Africa: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 83 Rest of Middle East & Africa: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 84 Rest of Middle East & Africa: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 85 Latin America: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 86 Latin America: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 87 Latin America: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 88 Mexico: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 89 Mexico: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 90 Mexico: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 91 Brazil: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 92 Brazil: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 93 Brazil: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 94 Argentina: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 95 Argentina: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 96 Argentina: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 97 Rest of Latin America: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 98 Rest of Latin America: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 99 Rest of Latin America: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • List of Figures:
  • Figure 1. Global Platinum-Based Cancer Drugs Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Platinum-Based Cancer Drugs Market, by Type, 2024 & 2034 (USD Million)
  • Figure 8. Market by Application
  • Figure 9. Global Platinum-Based Cancer Drugs Market, by Application, 2024 & 2034 (USD Million)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Platinum-Based Cancer Drugs Market, by Distribution Channel, 2024 & 2034 (USD Million)
目次
Product Code: PM1635

The global platinum-based cancer drugs market size is expected to reach USD 2,733.24 million by 2034, according to a new study by Polaris Market Research. The report "Platinum-Based Cancer Drugs Market Size, Share, Trends, Industry Analysis Report: By Type (Cisplatin, Oxaliplatin, Carboplatin, and Others), Application, Distribution Channel, and Region (North America, Europe, Asia Pacific, Latin America, and Middle, East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increasing prevalence of various cancers, such as ovarian, lung, and colorectal cancer, that require effective chemotherapy treatments drives the platinum-based cancer drugs market growth. Key market growth drivers include the continued effectiveness of platinum-based drugs such as cisplatin, carboplatin, and oxaliplatin in treating solid tumors and advancements in combination therapies and personalized medicine that enhance treatment outcomes. Opportunities exist in emerging markets where access to cancer treatments is expanding, as well as in the development of new drug formulations aimed at reducing side effects and improving drug delivery.

A few platinum-based cancer drugs market trends such as the rise of combination therapies, the focus on reducing toxicity, and the growing availability of generic platinum drugs would contribute to the market's overall expansion during the forecast period. As research progresses and new applications for platinum-based drugs are explored, the market is poised for continued growth, addressing both the demand for better cancer treatments and the need for affordable therapies worldwide.

Platinum-Based Cancer Drugs Market Report Highlights

Based on type, the Cisplatin segment dominates the platinum-based cancer drugs market share due to its long-standing use and effectiveness in treating various cancers, including ovarian and testicular cancer. However, the oxaliplatin segment is the fastest-growing, driven by its increasing application in colorectal cancer treatments and combination therapies.

The ovarian cancer segment, by application, holds the largest market share, owing to the high efficacy of platinum-based drugs such as cisplatin and carboplatin in treating this cancer. Lung cancer is the fastest-growing segment, primarily due to the rising incidence of non-small cell lung cancer and the use of platinum-based therapies in combination with other drugs.

By distribution channel, the hospital-based pharmacies segment dominates the market as they are the primary providers of chemotherapy drugs, including platinum-based treatments, for inpatient care and cancer treatments. Online pharmacies are experiencing the highest growth, driven by the increasing trend of remote healthcare and patient convenience for prescription refills and outpatient treatments.

North America holds the largest share of the global market, largely due to advanced healthcare infrastructure and high cancer incidence rates in the region. Asia Pacific is the highest-growing region, fueled by the increasing cancer burden, improving healthcare access, and rising adoption of platinum-based therapies in countries such as China and India.

Polaris Market Research has segmented the platinum-based cancer drugs market report on the basis of type, application, distribution channel, and region:

By Type Outlook (Revenue - USD Million, 2020-2034)

  • Cisplatin
  • Oxaliplatin
  • Carboplatin
  • Others

By Application Outlook (Revenue - USD Million, 2020-2034)

  • Colorectal Cancer
  • Ovarian Cancer
  • Lung Cancer
  • Others

By Distribution Channel Outlook (Revenue - USD Million, 2020-2034)

  • Hospital-Based Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Regional Outlook (Revenue - USD Million, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Platinum-Based Cancer Drugs Market Insights

  • 4.1. Platinum-Based Cancer Drugs Market - Market Snapshot
  • 4.2. Platinum-Based Cancer Drugs Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Adoption of Platinum-Based Chemotherapy in Cancer Treatment
      • 4.2.1.2. Ongoing Research in Combination Therapies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Platinum-Based Cancer Drugs Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Platinum-Based Cancer Drugs Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • 5.3. Cisplatin
    • 5.3.1. Global Platinum-Based Cancer Drugs Market, by Cisplatin, by Region, 2020-2034 (USD Million)
  • 5.4. Oxaliplatin
    • 5.4.1. Global Platinum-Based Cancer Drugs Market, by Oxaliplatin, by Region, 2020-2034 (USD Million)
  • 5.5. Carboplatin
    • 5.5.1. Global Platinum-Based Cancer Drugs Market, by Carboplatin, by Region, 2020-2034 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Platinum-Based Cancer Drugs Market, by Others, by Region, 2020-2034 (USD Million)

6. Global Platinum-Based Cancer Drugs Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • 6.3. Colorectal Cancer
    • 6.3.1. Global Platinum-Based Cancer Drugs Market, by Colorectal Cancer, by Region, 2020-2034 (USD Million)
  • 6.4. Ovarian Cancer
    • 6.4.1. Global Platinum-Based Cancer Drugs Market, by Ovarian Cancer, by Region, 2020-2034 (USD Million)
  • 6.5. Lung Cancer
    • 6.5.1. Global Platinum-Based Cancer Drugs Market, by Lung Cancer, by Region, 2020-2034 (USD Million)
  • 6.6. Others
    • 6.6.1. Global Platinum-Based Cancer Drugs Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Platinum-Based Cancer Drugs Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • 7.3. Hospital-Based Pharmacies
    • 7.3.1. Global Platinum-Based Cancer Drugs Market, by Hospital-Based Pharmacies, by Region, 2020-2034 (USD Million)
  • 7.4. Retail Pharmacies
    • 7.4.1. Global Platinum-Based Cancer Drugs Market, by Retail Pharmacies, by Region, 2020-2034 (USD Million)
  • 7.5. Online Pharmacies
    • 7.5.1. Global Platinum-Based Cancer Drugs Market, by Online Pharmacies, by Region, 2020-2034 (USD Million)

8. Global Platinum-Based Cancer Drugs Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Platinum-Based Cancer Drugs Market Assessment, By Geography, 2020-2034 (USD Million)
  • 8.3. Platinum-Based Cancer Drugs Market - North America
    • 8.3.1. North America: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
    • 8.3.2. North America: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
    • 8.3.3. North America: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.3.4. Platinum-Based Cancer Drugs Market - U.S.
      • 8.3.4.1. U.S.: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.3.4.2. U.S.: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.3.4.3. U.S.: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.3.5. Platinum-Based Cancer Drugs Market - Canada
      • 8.3.5.1. Canada: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.3.5.2. Canada: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.3.5.3. Canada: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • 8.4. Platinum-Based Cancer Drugs Market - Europe
    • 8.4.1. Europe: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
    • 8.4.2. Europe: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
    • 8.4.3. Europe: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.4. Platinum-Based Cancer Drugs Market - UK
      • 8.4.4.1. UK: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.4.4.2. UK: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.4.4.3. UK: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.5. Platinum-Based Cancer Drugs Market - France
      • 8.4.5.1. France: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.4.5.2. France: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.4.5.3. France: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.6. Platinum-Based Cancer Drugs Market - Germany
      • 8.4.6.1. Germany: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.4.6.2. Germany: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.4.6.3. Germany: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.7. Platinum-Based Cancer Drugs Market - Italy
      • 8.4.7.1. Italy: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.4.7.2. Italy: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.4.7.3. Italy: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.8. Platinum-Based Cancer Drugs Market - Spain
      • 8.4.8.1. Spain: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.4.8.2. Spain: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.4.8.3. Spain: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.9. Platinum-Based Cancer Drugs Market - Netherlands
      • 8.4.9.1. Netherlands: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.4.9.2. Netherlands: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.4.9.3. Netherlands: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.10. Platinum-Based Cancer Drugs Market - Russia
      • 8.4.10.1. Russia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.4.10.2. Russia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.4.10.3. Russia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.11. Platinum-Based Cancer Drugs Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.4.11.2. Rest of Europe: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.4.11.3. Rest of Europe: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • 8.5. Platinum-Based Cancer Drugs Market - Asia Pacific
    • 8.5.1. Asia Pacific: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
    • 8.5.2. Asia Pacific: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
    • 8.5.3. Asia Pacific: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.4. Platinum-Based Cancer Drugs Market - China
      • 8.5.4.1. China: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.5.4.2. China: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.5.4.3. China: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.5. Platinum-Based Cancer Drugs Market - India
      • 8.5.5.1. India: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.5.5.2. India: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.5.5.3. India: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.6. Platinum-Based Cancer Drugs Market - Malaysia
      • 8.5.6.1. Malaysia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.5.6.2. Malaysia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.5.6.3. Malaysia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.7. Platinum-Based Cancer Drugs Market - Japan
      • 8.5.7.1. Japan: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.5.7.2. Japan: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.5.7.3. Japan: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.8. Platinum-Based Cancer Drugs Market - Indonesia
      • 8.5.8.1. Indonesia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.5.8.2. Indonesia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.5.8.3. Indonesia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.9. Platinum-Based Cancer Drugs Market - South Korea
      • 8.5.9.1. South Korea: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.5.9.2. South Korea: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.5.9.3. South Korea: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.10. Platinum-Based Cancer Drugs Market - Australia
      • 8.5.10.1. Australia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.5.10.2. Australia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.5.10.3. Australia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.11. Platinum-Based Cancer Drugs Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.5.11.2. Rest of Asia Pacific: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.5.11.3. Rest of Asia Pacific: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • 8.6. Platinum-Based Cancer Drugs Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
    • 8.6.2. Middle East & Africa: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
    • 8.6.3. Middle East & Africa: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.6.4. Platinum-Based Cancer Drugs Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.6.4.2. Saudi Arabia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.6.4.3. Saudi Arabia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.6.5. Platinum-Based Cancer Drugs Market - UAE
      • 8.6.5.1. UAE: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.6.5.2. UAE: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.6.5.3. UAE: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.6.6. Platinum-Based Cancer Drugs Market - Israel
      • 8.6.6.1. Israel: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.6.6.2. Israel: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.6.6.3. Israel: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.6.7. Platinum-Based Cancer Drugs Market - South Africa
      • 8.6.7.1. South Africa: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.6.7.2. South Africa: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.6.7.3. South Africa: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.6.8. Platinum-Based Cancer Drugs Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.6.8.2. Rest of Middle East & Africa: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.6.8.3. Rest of Middle East & Africa: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • 8.7. Platinum-Based Cancer Drugs Market - Latin America
    • 8.7.1. Latin America: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
    • 8.7.2. Latin America: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
    • 8.7.3. Latin America: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.7.4. Platinum-Based Cancer Drugs Market - Mexico
      • 8.7.4.1. Mexico: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.7.4.2. Mexico: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.7.4.3. Mexico: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.7.5. Platinum-Based Cancer Drugs Market - Brazil
      • 8.7.5.1. Brazil: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.7.5.2. Brazil: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.7.5.3. Brazil: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.7.6. Platinum-Based Cancer Drugs Market - Argentina
      • 8.7.6.1. Argentina: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.7.6.2. Argentina: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.7.6.3. Argentina: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.7.7. Platinum-Based Cancer Drugs Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.7.7.2. Rest of Latin America: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.7.7.3. Rest of Latin America: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Bristol-Myers Squibb
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Eli Lilly and Company
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Sanofi
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Pfizer
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Novartis
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Johnson & Johnson
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Teva Pharmaceutical Industries
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Hikma Pharmaceuticals
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Mylan
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. AstraZeneca
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. GlaxoSmithKline
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Bayer
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Merck & Co.
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Amgen
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Sun Pharmaceutical Industries
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development